Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shuhei Kishikawa"'
Autor:
Yasuyuki Kaneta, Takahiko Seki, Osamu Ubukata, Yumi Matsui, Shuhei Kishikawa, Takashi Shimada, Toshiki Tabata, Sho Takechi, Kosuke Takeuchi, Takeshi Shida, Yoshihiro Shibata, Ryo Murakami, Mana Hatanaka, Yoichi Munehira, Kohei Takano
Supplementary Tables from Discovery of a Novel ATP-Competitive MEK Inhibitor DS03090629 that Overcomes Resistance Conferred by BRAF Overexpression in BRAF-Mutated Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63db35c90bd3fa1e8ea96916e9e0705f
https://doi.org/10.1158/1535-7163.22523761.v1
https://doi.org/10.1158/1535-7163.22523761.v1
Autor:
Yasuyuki Kaneta, Takahiko Seki, Osamu Ubukata, Yumi Matsui, Shuhei Kishikawa, Takashi Shimada, Toshiki Tabata, Sho Takechi, Kosuke Takeuchi, Takeshi Shida, Yoshihiro Shibata, Ryo Murakami, Mana Hatanaka, Yoichi Munehira, Kohei Takano
Supplementary Figures from Discovery of a Novel ATP-Competitive MEK Inhibitor DS03090629 that Overcomes Resistance Conferred by BRAF Overexpression in BRAF-Mutated Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22757ff9c78ad64b565af1b3c30e1dd4
https://doi.org/10.1158/1535-7163.22523767
https://doi.org/10.1158/1535-7163.22523767
Autor:
Yasuyuki Kaneta, Takahiko Seki, Osamu Ubukata, Yumi Matsui, Shuhei Kishikawa, Takashi Shimada, Toshiki Tabata, Sho Takechi, Kosuke Takeuchi, Takeshi Shida, Yoshihiro Shibata, Ryo Murakami, Mana Hatanaka, Yoichi Munehira, Kohei Takano
Supplementary Methods from Discovery of a Novel ATP-Competitive MEK Inhibitor DS03090629 that Overcomes Resistance Conferred by BRAF Overexpression in BRAF-Mutated Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f2c64c2d11235ff09916379c8ca2dd8
https://doi.org/10.1158/1535-7163.22523764.v1
https://doi.org/10.1158/1535-7163.22523764.v1
Autor:
Kohei Takano, Yoichi Munehira, Mana Hatanaka, Ryo Murakami, Yoshihiro Shibata, Takeshi Shida, Kosuke Takeuchi, Sho Takechi, Toshiki Tabata, Takashi Shimada, Shuhei Kishikawa, Yumi Matsui, Osamu Ubukata, Takahiko Seki, Yasuyuki Kaneta
Publikováno v:
Molecular cancer therapeutics.
Patients with melanoma with activating BRAF mutations (BRAF V600E/K) initially respond to combination therapy of BRAF and MEK inhibitors. However, their clinical efficacy is limited by acquired resistance, in some cases driven by amplification of the
Publikováno v:
The Journal of Biochemistry. 169:491-496
P2X4 receptor is known to be involved in neuropathic pain. In order to detect the expression of P2X4 receptor on microglia at the time of onset of neuropathic pain, one approach consists on the preparation of the monoclonal antibodies with both selec
Autor:
Hidetoshi Tozaki-Saitoh, Tomohiro Yamashita, Saki Nagai, Chinatsu Shinozaki, Shuhei Kishikawa, Tadashi Ueda, Mitsunori Shiroishi, Hiroyuki Tanaka, Makoto Tsuda, Tatsuhiro Igawa, Kazuhide Inoue, Yoshito Abe
Publikováno v:
Purinergic Signalling. 15:27-35
P2X purinergic receptors are ATP-driven ionic channels expressed as trimers and showing various functions. A subtype, the P2X4 receptor present on microglial cells is highly involved in neuropathic pain. In this study, in order to prepare antibodies